Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Henlius Biotech (2696 HK)
Watchlist
117
Analysis
Health Care
•
China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Henlius Biotech
•
01 Jul 2024 00:27
Merger Arb Mondays (01 Jul) - Henlius, China TCM, GA Pack, CPMC, Asia Cement, Great Eastern
This week, the highest gross spreads are HEC Pharma (121.3%), China TCM (26.7%), Hollysys (22.5%), Ansarada (13.1%), Asia Cement China (12.6%), A8...
Arun George
Follow
405 Views
Share
bearish
•
Shanghai Henlius Biotech
•
26 Jun 2024 08:55
Shanghai Henlius Biotech Privatization (2696.HK) - The Offer Price Is Disappointing
The Cancellation Price is 50% lower than Henlius's IPO price, causing losses for long-term players. Remaining public will provide good returns....
Xinyao (Criss) Wang
Follow
439 Views
Share
bullish
•
Shanghai Henlius Biotech
•
25 Jun 2024 09:39
Henlius Biotech (2696 HK): Fosun Pharma's "Fair" Offer
I'd be buying Henlius up to around $23.30 or a gross/annualised spread of 5%/15%, assuming early mid-November completion.
David Blennerhassett
Follow
319 Views
Share
bullish
•
Shanghai Henlius Biotech
•
25 Jun 2024 02:18
Henlius (2696 HK): Fosun Pharma’s HK$24.60 Offer at Around Half the IPO Price
Long-term investors will be unimpressed as the offer is half the HK$49.60 IPO price. However, shareholders with blocking stakes should be...
Arun George
Follow
327 Views
Share
bearish
•
Shanghai Henlius Biotech
•
27 May 2024 08:30
Shanghai Henlius Biotech (2696.HK) - Behind the Trading Halt and Privatization Rumor
Rumors swirl around Henlius's trading halt, raising questions about privatization.Henlius faces challenge in the market due to high debt, with...
Xinyao (Criss) Wang
Follow
340 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x